Evidence map›Paper›PMID 36524067›Full record

ArticleJournal of thoracic disease2022

The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer.

Connor J Wakefield, Nicholas Lund, Julia Coughlin, Justin M Karush, Nicole Geissen, Gillian Alex, Michael J Liptay, Jeffrey A Borgia, Palmi Shah, Christopher W Seder

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The process to overcome lung cancer sarcopenia.Journal of thoracic disease · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Connor J WakefieldDepartment of Internal Medicine, Brooke Army Medical Center, San Antonio, TX, USA.
Nicholas LundDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Julia CoughlinDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Justin M KarushDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Nicole GeissenDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Gillian AlexDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Michael J LiptayDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Jeffrey A BorgiaDepartments of Pathology and Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL, USA.
Palmi ShahDepartment of Radiology, Rush University Medical Center, Chicago, IL, USA.
Christopher W SederDepartment of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
Rush University Medical Center · USBrooke Army Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sarcopenia, as measured at the 3rd lumbar (L3) level, has been shown to prognosticate survival in cancer patients. However, many patients with early-stage non-small cell lung cancer (NSCLC) do not undergo abdominal imaging. We hypothesized that preoperative thoracic sarcopenia is associated with survival in patients undergoing lung resection for early-stage NSCLC. Methods: Patients who underwent anatomic resection for NSCLC between 2010-2019 were retrospectively identified. Exclusion criteria included induction therapy, less than 90 days of follow-up, and absence of computed tomography (CT) imaging. Cross sectional skeletal muscle area was calculated at the fifth thoracic vertebra (T5), twelfth thoracic vertebra (T12), and L3 level. Gender-specific lowest quartile values and previously defined values were used to define sarcopenia. Overall survival and disease-free survival were assessed using the Kaplan-Meier method. Results: Overall, 221 patients met inclusion criteria with a median body mass index (BMI) of 26.5 kg/m Conclusions: Sarcopenia at T5 is associated with worse survival in males, but not females. When using upper thoracic vertebral levels to assess for sarcopenia, it is necessary to account for gender.

Indexed as

anatomic lung resectionearly stagenon-small cell lung cancer (NSCLC)Sarcopeniathoracic sarcopenia

Identifiers

PMID36524067
PMCPMC9745523
OpenAlexW4310811751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.